Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression.
Soufivand P, Hosseini Torshizi G, Roghani SA, Dastbaz M, Lotfi R, Soleymani B, Heydarpour F, Abdan Z, Allahyari H. Soufivand P, et al. Inflammopharmacology. 2024 Dec;32(6):3687-3695. doi: 10.1007/s10787-024-01565-1. Epub 2024 Sep 4. Inflammopharmacology. 2024. PMID: 39231852
Increased gene expression of CCR6 and RORγt in peripheral blood cells of rheumatoid arthritis patients and their correlation with anti-cyclic citrullinated peptide and disease activity.
Roghani SA, Lotfi R, Soroush MG, Khorasanizadeh A, Feizollahi P, Assar S, Soufivand P, Pournazari M, Mohammadi Kish Z, Taghadosi M. Roghani SA, et al. Among authors: soufivand p. Immun Inflamm Dis. 2023 Dec;11(12):e1112. doi: 10.1002/iid3.1112. Immun Inflamm Dis. 2023. PMID: 38156398 Free PMC article.
Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone.
Karamali N, Mahmoudi Z, Roghani SA, Assar S, Pournazari M, Soufivand P, Karaji AG, Rezaiemanesh A. Karamali N, et al. Among authors: soufivand p. Clin Rheumatol. 2024 Jan;43(1):147-157. doi: 10.1007/s10067-023-06808-0. Epub 2023 Dec 4. Clin Rheumatol. 2024. PMID: 38049563 Clinical Trial.
Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report.
Assar S, Mohammadzadeh D, Norooznezhad AH, Payandeh M, Hassaninia D, Pournazari M, Soufivand P, Yarani R, Mansouri K. Assar S, et al. Among authors: soufivand p. Respir Med Case Rep. 2023 Oct 2;46:101923. doi: 10.1016/j.rmcr.2023.101923. eCollection 2023. Respir Med Case Rep. 2023. PMID: 37928415 Free PMC article.
19 results